Omani Fund joins $200mln Chinese AI funding round
Resumen detallado
The company is initially concentrating on scientific discovery and pharmaceutical research, including drug target identification, molecular screening ...
MUSCAT - Leading Chinese artificial intelligence and robotics company MegaRobo Technologies announced on Thursday that it has raised nearly $200 million in a major new funding round, with participation from an Omani state-backed investment fund. The investment further underscores the deepening economic and financial ties between the Sultanate of Oman and China, particularly in advanced technologies and innovation-driven industries.
Beijing-headquartered MegaRobo said in a statement that the funding round attracted participation from several prominent international investors, including CMB International, Asia Investment Capital, Granite Asia and Sinovation Ventures.
The investment comes amid a notable upswing in bilateral economic engagement, highlighted by His Majesty Sultan Haitham bin Tarik's first state visit to China earlier this month, which provided fresh impetus to cooperation in manufacturing, renewable energy, technology and strategic investments.
MegaRobo, which specialises in developing intelligent infrastructure connecting artificial intelligence with real-world scientific and industrial processes, said the new financing would support core technology development, international expansion and the growth of its AI for Science business.
Central to its technological offering is the proprietary One Intelligence Stack, an integrated platform combining AI models, scientific computing, robotics, laboratory automation, software and real-time experimental feedback.
Unlike conventional AI applications that primarily analyse existing information, MegaRobo's technology enables intelligent systems to design and execute experiments, observe results and continuously refine their decision-making capabilities.
The company is initially concentrating on scientific discovery and pharmaceutical research, including drug target identification, molecular screening and optimisation of potential drug candidates.
Its Megalaxy Lab platform, serving over 200 customers, enables researchers…
Da…
Inicio del artículo, extracto de Zawya. Para leer el resto, abra el artículo en el sitio del medio.
MarketNews muestra el titular y el resumen publicados por el medio. El artículo completo se lee en el sitio del editor. (www.zawya.com)

